Syfovre's Competitive Edge Highlights Bright Future For Apellis Pharmaceuticals, Analyst Initiates With Bullish Pitch - Apellis Pharmaceuticals ( NASDAQ:APLS )
William Blair has initiated coverage on Apellis Pharmaceuticals, Inc.
| Ticker |
Sentiment |
Impact |
|
APLS
|
Somewhat Bullish
|
29 %
|
|
ALPMF
|
Somewhat Bullish
|
19 %
|
